-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Market Perform on Allogene Therapeutics, Raises Price Target to $3.85

Benzinga·04/14/2026 15:37:43
Listen to the news
Argus Research analyst William Pickering maintains Allogene Therapeutics (NASDAQ:ALLO) with a Market Perform and raises the price target from $1.6 to $3.85.